Attorneys handling Ozempic cases must demonstrate expertise developed through years of focused pharmaceutical practice: Direct participation in previous pharmaceutical MDLs or mass tort cases involving dangerous drugs or medical devices Proven ability to work with medical experts, toxicologists, and regulatory specialists who can establish causation Track record of securing favorable settlements or verdicts in cases involving failure-to-warn claims against drug manufacturers Familiarity with FDA regulatory processes, label warning requirements, and post-market surveillance obligations Experience handling Daubert challenges and defending expert testimony under federal evidence rules Attorneys with pharmaceutical litigation backgrounds possess institutional knowledge about how drug manufacturers operate, how FDA approval processes work, and what evidence typically exists in corporate files to support failure-to-warn claims
But he did not get very far until he teamed up with John Eng (figure 33), a research fellow working with Yalow, the co-pioneer of RIA, at the Bronx VA Hospital
The paper was published in Annals of Surgery
Skin-lightening claims (unproven): Marketed for skin whitening, but IV/injectable glutathione is not FDA-approved for this and evidence is weak
Rectal administration of fecal transplants from 2 to 4-month-old healthy mice into lupus model mice rebalanced the gut microbiota and alleviated lupus severity [79] 61
